Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (19 quarters reported)
$741M in Q4 2021 → $78.6M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Evolv Technologies Holdings, Inc. | 33.9% | Unchanged | 4,590,000 | $26.6M |
| Horizon Quantum Holdings Ltd | 32.3% | Unchanged | 915,198 | $25.4M |
| Recursion Pharmaceuticals, Inc. | 27.8% | Unchanged | 5,941,120 | $21.8M |
| DT Definium Therapeutics, Inc. (mindmed) | 6.0% | Unchanged | 100,350 | $4.72M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Horizon Quantum Holdings Ltd | New | +915,198 | +$8.04M | 14.4% |
| DT Definium Therapeutics, Inc. (mindmed) | New | +100,350 | +$1.9M | 3.4% |
| MM Mind Medicine (mindmed) Inc. | Exited | −100,350 | −$1.34M | — |
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Evolv Technologies Holdings, Inc. | Trimmed | −410,000 | −$2.94M | 56.2% |
| Roivant Sciences Ltd. | Exited | −3,875 | −$58.6K | — |
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Rocket Lab Corp | Exited | −1,083,053 | −$38.7M | — |
| Evolv Technologies Holdings, Inc. | Trimmed | −4,681,281 | −$35.3M | 55.5% |
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Rocket Lab Corp | New | +1,083,053 | +$38.7M | 29.8% |
| RL Rocket Lab Usa, Inc. | Exited | −1,377,943 | −$24.6M | — |
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Oklo Inc. | Exited | −5,277,513 | −$112M | — |
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| RL Rocket Lab Usa, Inc. | Trimmed | −1,551,407 | −$39.5M | 15.5% |
| Oklo Inc. | Trimmed | −1,643,291 | −$34.9M | 49.5% |
quarter ended September 30, 2024 · filed November 14, 2024
No position changes this quarter.
Loading...
